Kin­nate Bio­phar­ma touts ear­ly ef­fi­ca­cy in pan-RAF pro­gram: #AACR23

3 years ago
R&D

Eli Lil­ly in­vests an­oth­er $1.6B in­to In­di­ana man­u­fac­tur­ing sites

3 years ago
Pharma
Manufacturing

Gami­da Cell wins FDA ap­proval for new cord blood-based ther­a­py for can­cer pa­tients

3 years ago
FDA+

Abor­tion pill can't just 's­nap back' to pre-2016, FDA's Wood­cock tells SCO­TUS

3 years ago
FDA+

Apel­lis rais­es un­com­mon eye dis­ease pro­file with ‘The Fonz’ ac­tor Hen­ry Win­kler

3 years ago
Pharma
Marketing

Vax­cyte un­veils new da­ta on chal­lenger to Pfiz­er’s Pre­vnar, heads to­ward PhI­II

3 years ago
R&D

Re­gen­eron chair­man Roy Vage­los will re­tire, and Len Schleifer and George Yan­copou­los will co-lead the board

3 years ago
People

Smart Im­mune picks up $5M from Gates Foun­da­tion; Ox­ford Nanopore teams up with French di­ag­nos­tics play­er

3 years ago
News Briefing

Re­gen­eron re­veals da­ta be­hind de­pri­or­i­tized BC­MA/CD3 bis­pe­cif­ic: #AACR23

3 years ago
R&D

J&J’s Janssen taps in­to Pipeline Ther­a­peu­tics’ neu­ro­science as­set for $50M up­front

3 years ago
Deals

Mod­er­na de­buts cor­po­rate ad cam­paign 'telling the sto­ry of mR­NA’ across its am­bi­tions

3 years ago
Pharma
Marketing

Japan­ese CRO buys back pen­ny stock spin­out while await­ing FDA de­ci­sion on mi­graine can­di­date

3 years ago
Deals

GSK stopped two UTI an­tibi­ot­ic tri­als ear­ly af­ter meet­ing ef­fi­ca­cy end­points. Now it’s shar­ing the full da­ta

3 years ago
R&D

Ex­clu­sive: Gen­mab's CEO touts M&A po­ten­tial as it inks first part­ner­ship out­side can­cer

3 years ago
Deals

VCs 'Com­ple­men­t' Eu­ro­pean biotech with $79M for reti­nal AAV gene ther­a­py tri­al next year

3 years ago
Financing
Startups

Roche's com­bo ther­a­py re­duces risk of liv­er can­cer re­turn­ing but rais­es safe­ty ques­tions: #AACR23

3 years ago
R&D

Up­dat­ed: Mer­ck buys Prometheus for $10.8B, bring­ing pre­ci­sion can­cer chops to a po­ten­tial IBD block­buster

3 years ago
Deals

As­traZeneca lines up com­pe­ti­tion with Mer­ck in lung can­cer be­fore and af­ter surgery: #AACR23

3 years ago
R&D

Mer­ck­'s Keytru­da-chemo re­duces risk of death from bil­iary tract can­cer by 17%: #AACR23

3 years ago
R&D

Mod­er­na and Mer­ck pre­pare for PhI­II tri­al of can­cer vac­cine, and an ex­pan­sion to lung can­cer: #AACR23

3 years ago
R&D
Pharma

Lat­est on re­ver­ber­a­tions of abor­tion pill rul­ing; Biotech ven­ture fund­ing dips; No­vo Nordisk dives in­to di­a­betes cell ...

3 years ago
Weekly

Years be­fore $43B Pfiz­er deal, a mys­tery com­pa­ny made six pro­pos­als for Seagen

3 years ago
Deals
Pharma

Supreme Court steps in to stay Texas court's rul­ing on mifepri­s­tone

3 years ago
Pharma

FDA ad­comm votes in fa­vor of first drug for ag­i­ta­tion as­so­ci­at­ed with Alzheimer's de­men­tia

3 years ago
FDA+
First page Previous page 356357358359360361362 Next page Last page
A service from the Financial Times